Literature DB >> 25016284

microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion.

Amit Bera1, Falguni Das1, Nandini Ghosh-Choudhury2, Balakuntalam S Kasinath3, Hanna E Abboud3, Goutam Ghosh Choudhury4.   

Abstract

Renal cancer metastasis may result from oncogenic forces that contribute to the primary tumor. We have recently identified microRNA-21 as an oncogenic driver of renal cancer cells. The mechanism by which miR-21 controls renal cancer cell invasion is poorly understood. We show that miR-21 directly downregulates the proapoptotic protein PDCD4 to increase migration and invasion of ACHN and 786-O renal cancer cells as a result of phosphorylation/activation of Akt and IKKβ, which activate NFκB-dependent transcription. Constitutively active (CA) Akt or CA IKKβ blocks PDCD4-mediated inhibition and restores renal cancer cell migration and invasion. PDCD4 inhibits mTORC1 activity, which was reversed by CA IKKβ. Moreover, CA mTORC1 restores cell migration and invasion inhibited by PDCD4 and dominant negative IKKβ. Moreover, PDCD4 negatively regulates mTORC2-dependent Akt phosphorylation upstream of this cascade. We show that PDCD4 forms a complex with rictor, an exclusive component of mTORC2, and that this complex formation is reduced in renal cancer cells due to increased miR-21 expression resulting in enhanced phosphorylation of Akt. Thus our results identify a previously unrecognized signaling node where high miR-21 levels reduce rictor-PDCD4 interaction to increase phosphorylation of Akt and contribute to metastatic fitness of renal cancer cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt kinase; Renal carcinoma; mTOR; miR-21

Mesh:

Substances:

Year:  2014        PMID: 25016284      PMCID: PMC4177976          DOI: 10.1016/j.yexcr.2014.06.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  129 in total

1.  Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Nirmalya Dey; Chandi Charan Mandal; Lenin Mahimainathan; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

2.  Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma.

Authors:  Koviljka Matušan-Ilijaš; Giuseppe Damante; Dora Fabbro; Gordana Dorđević; Ita Hadžisejdić; Maja Grahovac; Ivana Marić; Josip Spanjol; Blaženka Grahovac; Nives Jonjić; Ksenija Lučin
Journal:  Pathol Res Pract       Date:  2010-12-16       Impact factor: 3.250

3.  MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Authors:  Raffaele Baffa; Matteo Fassan; Stefano Volinia; Brian O'Hara; Chang-Gong Liu; Juan P Palazzo; Marina Gardiman; Massimo Rugge; Leonard G Gomella; Carlo M Croce; Anne Rosenberg
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

4.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

5.  Isolation of hyperactive mutants of mammalian target of rapamycin.

Authors:  Yoichiro Ohne; Terunao Takahara; Riko Hatakeyama; Tomoko Matsuzaki; Makoto Noda; Noboru Mizushima; Tatsuya Maeda
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

6.  Microarray analysis of microRNA expression in renal clear cell carcinoma.

Authors:  Y Huang; Y Dai; J Yang; T Chen; Y Yin; M Tang; C Hu; L Zhang
Journal:  Eur J Surg Oncol       Date:  2009-05-13       Impact factor: 4.424

7.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

8.  Targeted disruption of c-myb in the chicken pre B-cell line DT40.

Authors:  Hartmut Appl; Karl-Heinz Klempnauer
Journal:  Oncogene       Date:  2002-05-02       Impact factor: 9.867

9.  MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.

Authors:  Qing Yao; Hui Xu; Qian-Qian Zhang; Hui Zhou; Liang-Hu Qu
Journal:  Biochem Biophys Res Commun       Date:  2009-08-12       Impact factor: 3.575

Review 10.  MicroRNAs and their role in progressive kidney diseases.

Authors:  Mitsuo Kato; Laura Arce; Rama Natarajan
Journal:  Clin J Am Soc Nephrol       Date:  2009-07       Impact factor: 8.237

View more
  26 in total

1.  p85α is a microRNA target and affects chemosensitivity in pancreatic cancer.

Authors:  Paul A Toste; Luyi Li; Brian E Kadera; Andrew H Nguyen; Linh M Tran; Nanping Wu; David L Madnick; Sanjeet G Patel; David W Dawson; Timothy R Donahue
Journal:  J Surg Res       Date:  2015-03-06       Impact factor: 2.192

2.  PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway.

Authors:  Hong-Yun Zheng; Fu-Jin Shen; Yong-Qing Tong; Yan Li
Journal:  Curr Med Sci       Date:  2018-03-15

Review 3.  Emerging Role of MicroRNAs in mTOR Signaling.

Authors:  Yanjie Zhang; Bo Huang; Hui-Yun Wang; Augustus Chang; X F Steven Zheng
Journal:  Cell Mol Life Sci       Date:  2017-02-25       Impact factor: 9.261

4.  miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma.

Authors:  Lie-Hao Jiang; Ming-Hua Ge; Xiu-Xiu Hou; Jun Cao; Si-Si Hu; Xiao-Xiao Lu; Jing Han; Yi-Chen Wu; Xiang Liu; Xin Zhu; Lian-Lian Hong; Pei Li; Zhi-Qiang Ling
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

5.  MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Authors:  Bo Fan; Yiying Jin; Hongshuo Zhang; Rui Zhao; Man Sun; Mengfan Sun; Xiaoying Yuan; Wei Wang; Xiaogang Wang; Zhiqi Chen; Wankai Liu; Na Yu; Qun Wang; Tingjiao Liu; Xiancheng Li
Journal:  Int J Oncol       Date:  2019-12-02       Impact factor: 5.650

6.  MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.

Authors:  Falguni Das; Nirmalya Dey; Amit Bera; Balakuntalam S Kasinath; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

7.  Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.

Authors:  Bo Sun; Liwei Chen; Hui Fu; Lin Guo; Hua Guo; Ning Zhang
Journal:  Tumour Biol       Date:  2015-10-25

Review 8.  Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.

Authors:  Tianying Xing; Huiying He
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

9.  AU-1 from Agavaceae plants causes transient increase in p21/Cip1 expression in renal adenocarcinoma ACHN cells in an miR-34-dependent manner.

Authors:  Tomofumi Fujino; Akihito Yokosuka; Hideaki Higurashi; Rina Yokokawa; Ryo Sakurai; Wataru Harashima; Yuichi Miki; Yasuyuki Fujiwara; Yoshihiro Mimaki; Makio Hayakawa
Journal:  J Nat Med       Date:  2016-07-07       Impact factor: 2.343

10.  Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

Authors:  Yury O Nunez Lopez; Berta Victoria; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.